HEPAHepion Pharmaceuticals, Inc.

About Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. (HEPA) is a Biotechnology company headquartered in Morristown, NJ, United States whose shares trade over-the-counter on the OTCQB tier.

Hepion is a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), helicobacter pylori (H. pylori) and hepatocellular carcinoma.

Products and services

Diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), helicobacter pylori (H. pylori) and hepatocellular carcinoma

HEPA key facts

Ticker symbol

HEPA

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Morristown, NJ, United States

Country of incorporation

US

Year of incorporation

2013

Employees

2

Estimated market cap

$490.6K (as of Aug 1, 2025)

Shares outstanding

11,434,890

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Jun 25, 2025)

Hepion Pharmaceuticals, Inc. leadership

• Kaouthar Lbiati — CEO
• Jeffrey Fessler — General Counsel

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with H